Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7515924rdf:typepubmed:Citationlld:pubmed
pubmed-article:7515924lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0021753lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0079459lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0206190lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0023767lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0023810lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0162493lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0392673lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C2348042lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0141826lld:lifeskim
pubmed-article:7515924lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:7515924pubmed:issue1lld:pubmed
pubmed-article:7515924pubmed:dateCreated1994-7-13lld:pubmed
pubmed-article:7515924pubmed:abstractTextHuman peritoneal macrophages were exposed to increasing doses of LPS or a synthetic lipid A analogue (SDZ MRL 953) and production of the cytokines IL-1 beta, IL-6, TNF-alpha, and G-CSF was assessed at the protein and mRNA level. Cells were also prestimulated with low doses of LPS and SDZ MRL 953 to study their adaptation to a secondary challenge with high doses of LPS. The ability of macrophages to produce high levels of TNF-alpha and IL-6 after stimulation with LPS could be relieved almost completely by preincubating cells with low doses of LPS. Decreases of TNF-alpha and IL-6 production resulted from inhibition of gene transcription and/or changes in mRNA stability, as transcript levels of these cytokines were down-modulated by the process of LPS adaptation. Surprisingly, however, adapted cells were able to synthesize even larger quantities of G-CSF and IL-1 beta when exposed to a secondary LPS challenge. mRNA levels of the adapted cells remained unaltered for IL-1 beta, but were slightly increased for G-CSF as assessed by Northern blot analysis. High doses of the synthetic lipid A analogue SDZ MRL 953 were also able to adapt macrophages to a secondary LPS challenge by down-regulating TNF-alpha and IL-6 production, whereas priming secretion of G-CSF and IL-1 beta as well. We describe here the discordant adaptation of human peritoneal macrophages to a secondary LPS stimulus in vitro. These findings appear to have ramifications for the in vivo endotoxin response during inflammation and also Gram-negative septicemia.lld:pubmed
pubmed-article:7515924pubmed:languageenglld:pubmed
pubmed-article:7515924pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7515924pubmed:statusMEDLINElld:pubmed
pubmed-article:7515924pubmed:monthJullld:pubmed
pubmed-article:7515924pubmed:issn0022-1767lld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:HerrmannFFlld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:GalanosCClld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:EngelhardtRRlld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:FreudenbergM...lld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:OttoFFlld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:SchumannR RRRlld:pubmed
pubmed-article:7515924pubmed:authorpubmed-author:KnopfH PHPlld:pubmed
pubmed-article:7515924pubmed:issnTypePrintlld:pubmed
pubmed-article:7515924pubmed:day1lld:pubmed
pubmed-article:7515924pubmed:volume153lld:pubmed
pubmed-article:7515924pubmed:ownerNLMlld:pubmed
pubmed-article:7515924pubmed:authorsCompleteYlld:pubmed
pubmed-article:7515924pubmed:pagination287-99lld:pubmed
pubmed-article:7515924pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:meshHeadingpubmed-meshheading:7515924-...lld:pubmed
pubmed-article:7515924pubmed:year1994lld:pubmed
pubmed-article:7515924pubmed:articleTitleDiscordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down-regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression.lld:pubmed
pubmed-article:7515924pubmed:affiliationDepartment of Internal Medicine I, Freiburg University Medical Center, Germany.lld:pubmed
pubmed-article:7515924pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7515924pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7515924lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7515924lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7515924lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7515924lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7515924lld:pubmed